Israel Englander Poseida Therapeutics, Inc. Transaction History

Millennium Management LLC

$192 Billion
Q4 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Poseida Therapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 136,116 shares of PSTX stock, worth $1.29 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

136,116

Previous 2,193,755 93.8%

Holding current value

$1.29 Million

Previous $6.27 Million 79.18%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$2.37 - $9.6 $4.88 Million - $19.8 Million	-2,057,639 Reduced 93.8%	136,116 $1.31 Million
Q3 2024 Nov 14, 2024	BUY	$2.7 - $4.04 $4.19 Million - $6.27 Million	1,550,785 Added 241.19%	2,193,755 $6.27 Million
Q2 2024 Aug 14, 2024	SELL	$2.0 - $3.46 $20,886 - $36,132	-10,443 Reduced 1.6%	642,970 $1.88 Million
Q1 2024 May 15, 2024	BUY	$2.76 - $4.13 $167,904 - $251,248	60,835 Added 10.27%	653,413 $2.08 Million
Q4 2023 Feb 14, 2024	SELL	$1.83 - $3.51 $1.01 Million - $1.94 Million	-551,773 Reduced 48.22%	592,578 $1.99 Million
Q2 2023 Aug 14, 2023	BUY	$1.66 - $3.4 $280,106 - $573,712	168,739 Added 17.3%	1,144,351 $2.01 Million
Q1 2023 May 15, 2023	SELL	$3.08 - $8.73 $2.07 Million - $5.86 Million	-671,285 Reduced 40.76%	975,612 $3.01 Million
Q4 2022 Feb 14, 2023	BUY	$3.33 - $6.38 $4.98 Million - $9.54 Million	1,495,099 Added 984.93%	1,646,897 $8.73 Million
Q3 2022 Nov 14, 2022	SELL	$2.43 - $4.51 $2.09 Million - $3.88 Million	-860,717 Reduced 85.01%	151,798 $536,000
Q2 2022 Aug 15, 2022	BUY	$1.87 - $5.0 $332,727 - $889,645	177,929 Added 21.32%	1,012,515 $2.61 Million
Q1 2022 May 16, 2022	SELL	$3.22 - $7.04 $199,408 - $435,973	-61,928 Reduced 6.91%	834,586 $3.74 Million
Q4 2021 Feb 14, 2022	SELL	$6.23 - $7.6 $83,120 - $101,399	-13,342 Reduced 1.47%	896,514 $6.11 Million
Q3 2021 Nov 15, 2021	SELL	$7.09 - $10.71 $966,133 - $1.46 Million	-136,267 Reduced 13.03%	909,856 $6.63 Million
Q2 2021 Aug 16, 2021	SELL	$7.96 - $10.07 $5.72 Million - $7.23 Million	-718,382 Reduced 40.71%	1,046,123 $10.5 Million
Q1 2021 May 17, 2021	BUY	$8.51 - $11.91 $2.47 Million - $3.45 Million	289,976 Added 19.67%	1,764,505 $16.9 Million
Q4 2020 Feb 16, 2021	BUY	$8.29 - $11.7 $8.36 Million - $11.8 Million	1,008,070 Added 216.11%	1,474,529 $16.2 Million
Q3 2020 Nov 16, 2020	BUY	$8.09 - $16.25 $3.77 Million - $7.58 Million	466,459 New	466,459 $4.14 Million

Others Institutions Holding PSTX

# of Institutions

119

Shares Held

40.7M

Call Options Held

135K

Put Options Held

439K

View Full List

About Poseida Therapeutics, Inc.

Ticker PSTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 85,775,600
Market Cap $815M
Description
Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...

More about PSTX

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account